• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

COVID-19 vaccines and Multiple sclerosis – update

February 26, 2021  

COVID-19 vaccines and Multiple sclerosis

February 11, 2021  

Novel anti-CD20 monoclonal approved in Canada for MS

January 27, 2021  

COVID vaccine guidance for MS patients

January 22, 2021  

Multiple sclerosis 2021 – a look ahead

January 13, 2021  

This just in – Winners of the 2020 Awards in Multiple Sclerosis

December 16, 2020  

McDonald 2017 update – more research required

December 9, 2020  

The Year in Review – virtual EBM and SPMS

December 2, 2020  

Ozanimod vs. fingolimod: is there a difference?

November 13, 2020  

B cell-directed therapies in MS – POST-ECTRIMS SPECIAL REPORT

October 23, 2020  
Previous
17
18
19
20
21
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Anti-CD20 therapy in MS: comparing efficacy and safety posted on July 21, 2026
  • Highlights of EAN 2026 – Part 1 posted on June 30, 2026
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions